Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 228

1.

Molecular evidence of field cancerization initiated by diabetes in colon cancer patients.

Del Puerto-Nevado L, Minguez P, Corton M, Solanes-Casado S, Prieto I, Mas S, Sanz AB, Gonzalez-Alonso P, Villaverde C, Portal-Nuñez S, Aguilera O, Gomez-Guerrero C, Esbrit P, Vivanco F, Gonzalez N, Ayuso C, Ortiz A, Rojo F, Egido J, Alvarez-Llamas G, Garcia-Foncillas J; DiabetesCancerConnect Consortium.

Mol Oncol. 2019 Jan 9. doi: 10.1002/1878-0261.12438. [Epub ahead of print]

2.

EphB2 stem-related and EphA2 progression-related miRNA-based networks in progressive stages of CRC evolution: clinical significance and potential miRNA drivers.

De Robertis M, Mazza T, Fusilli C, Loiacono L, Poeta ML, Sanchez M, Massi E, Lamorte G, Diodoro MG, Pescarmona E, Signori E, Pesole G, Vescovi AL, Garcia-Foncillas J, Fazio VM.

Mol Cancer. 2018 Nov 30;17(1):169. doi: 10.1186/s12943-018-0912-z.

3.

Prospective multicenter real-world RAS mutation comparison between OncoBEAM-based liquid biopsy and tissue analysis in metastatic colorectal cancer.

García-Foncillas J, Tabernero J, Élez E, Aranda E, Benavides M, Camps C, Jantus-Lewintre E, López R, Muinelo-Romay L, Montagut C, Antón A, López G, Díaz-Rubio E, Rojo F, Vivancos A.

Br J Cancer. 2018 Dec;119(12):1464-1470. doi: 10.1038/s41416-018-0293-5. Epub 2018 Nov 23.

PMID:
30467411
4.

Prognostic significance of neutrophil-to lymphocyte ratio and platelet-to lymphocyte ratio in older patients with metastatic colorectal cancer.

Cruz-Ramos M, Del Puerto-Nevado L, Zheng B, López-Bajo R, Cebrian A, Rodríguez-Remirez M, García-García L, Solanes-Casado S, García-Foncillas J.

J Geriatr Oncol. 2018 Oct 13. pii: S1879-4068(18)30256-X. doi: 10.1016/j.jgo.2018.10.002. [Epub ahead of print]

PMID:
30327283
5.

New Hope for Pancreatic Ductal Adenocarcinoma Treatment Targeting Endoplasmic Reticulum Stress Response: A Systematic Review.

Garcia-Carbonero N, Li W, Cabeza-Morales M, Martinez-Useros J, Garcia-Foncillas J.

Int J Mol Sci. 2018 Aug 21;19(9). pii: E2468. doi: 10.3390/ijms19092468. Review.

6.

Cancer and suicidal ideation and behaviours: protocol for a systematic review and meta-analysis.

Calati R, Fang F, Mostofsky E, Shen Q, Di Mattei VE, Garcia-Foncillas J, Baca-Garcia E, Cipriani A, Courtet P.

BMJ Open. 2018 Aug 10;8(8):e020463. doi: 10.1136/bmjopen-2017-020463.

7.

Analysis of Potential Alterations Affecting SETBP1 as a Novel Contributing Mechanism to Inhibit PP2A in Colorectal Cancer Patients.

Torrejón B, Cristóbal I, Caramés C, Prieto-Potín I, Chamizo C, Santos A, Sanz-Alvarez M, Serna-Blasco R, Luque M, Madoz-Gúrpide J, Rojo F, García-Foncillas J.

World J Surg. 2018 Nov;42(11):3771-3778. doi: 10.1007/s00268-018-4684-9.

PMID:
29796729
8.

Dissecting the therapeutic implications of the complex SMAD4 regulatory network in metastatic colorectal cancer.

Cristóbal I, Torrejón B, Santos A, Luque M, Sanz-Alvarez M, Rojo F, García-Foncillas J.

Eur J Surg Oncol. 2018 Aug;44(8):1283-1284. doi: 10.1016/j.ejso.2018.04.021. Epub 2018 May 9. No abstract available.

PMID:
29778618
9.

Potential Therapeutic Impact of miR-145 Deregulation in Colorectal Cancer.

Cristóbal I, Sanz-Alvarez M, Torrejón B, Santos A, Luque M, Rojo F, García-Foncillas J.

Mol Ther. 2018 Jun 6;26(6):1399-1400. doi: 10.1016/j.ymthe.2018.05.008. Epub 2018 May 18. No abstract available.

PMID:
29778522
10.

The clinical impact of using complex molecular profiling strategies in routine oncology practice.

Laes JF, Aftimos P, Barthelemy P, Bellmunt J, Berchem G, Camps C, Peñas RL, Finzel A, García-Foncillas J, Hervonen P, Wahid I, Joensuu T, Kathan L, Kong A, Mackay J, Mikropoulos C, Mokbel K, Mouysset JL, Odarchenko S, Perren TJ, Pienaar R, Regonesi C, Alkhayyat SS, El Kinge AR, Abulkhair O, Galal KM, Ghanem H, El Karak F, Garcia A, Ghitti G, Sadik H.

Oncotarget. 2018 Apr 17;9(29):20282-20293. doi: 10.18632/oncotarget.24757. eCollection 2018 Apr 17.

11.

Laparoscopic paraaortic surgical staging in locally advanced cervical cancer: a single-center experience.

Vázquez-Vicente D, Fernández Del Bas B, García Villayzán J, Di Fiore HA, Luna Tirado J, Casado Echarren V, García-Foncillas J, Plaza Arranz J, Chiva L.

Clin Transl Oncol. 2018 Nov;20(11):1455-1459. doi: 10.1007/s12094-018-1878-4. Epub 2018 Apr 18.

PMID:
29671223
12.

Prognostic value of Ki-67 according to age in patients with triple-negative breast cancer.

Zenzola V, Cabezas-Quintario MA, Arguelles M, Pérez-Fernández E, Izarzugaza Y, Correa A, García-Foncillas J.

Clin Transl Oncol. 2018 Nov;20(11):1448-1454. doi: 10.1007/s12094-018-1877-5. Epub 2018 Apr 18.

PMID:
29671222
13.

Comment on 'MicroRNA-199b-5p attenuates TGF-β1-induced epithelial-mesenchymal transition in hepatocellular carcinoma'.

Cristóbal I, Santos A, González S, Luque M, Torrejón B, Rojo F, García-Foncillas J.

Br J Cancer. 2018 Apr;118(7):1028-1029. doi: 10.1038/s41416-018-0013-1. Epub 2018 Mar 19. No abstract available.

PMID:
29551773
14.

Targeting the RAS-dependent chemoresistance: The Warburg connection.

Serna-Blasco R, Sanz-Álvarez M, Aguilera Ó, García-Foncillas J.

Semin Cancer Biol. 2018 Feb 9. pii: S1044-579X(17)30272-9. doi: 10.1016/j.semcancer.2018.01.016. [Epub ahead of print] Review.

PMID:
29432815
15.

The potential predictive value of DEK expression for neoadjuvant chemoradiotherapy response in locally advanced rectal cancer.

Martinez-Useros J, Moreno I, Fernandez-Aceñero MJ, Rodriguez-Remirez M, Borrero-Palacios A, Cebrian A, Gomez Del Pulgar T, Del Puerto-Nevado L, Li W, Puime-Otin A, Perez N, Soengas MS, Garcia-Foncillas J.

BMC Cancer. 2018 Feb 6;18(1):144. doi: 10.1186/s12885-018-4048-8.

16.

Potential contribution of SET and c-MYC deregulation to promote extracellular matrix remodelling in hepatocellular carcinoma.

Cristóbal I, Torrejón B, Rojo F, García-Foncillas J.

Br J Pharmacol. 2018 Feb;175(3):573-574. doi: 10.1111/bph.14108. Epub 2018 Jan 5. No abstract available.

PMID:
29313882
17.

Rationale for combination of therapeutic antibodies targeting tumor cells and immune checkpoint receptors: Harnessing innate and adaptive immunity through IgG1 isotype immune effector stimulation.

Ferris RL, Lenz HJ, Trotta AM, García-Foncillas J, Schulten J, Audhuy F, Merlano M, Milano G.

Cancer Treat Rev. 2018 Feb;63:48-60. doi: 10.1016/j.ctrv.2017.11.008. Epub 2017 Dec 2. Review.

18.

Clinical Implications of NRAS Overexpression in Resectable Pancreatic Adenocarcinoma Patients.

Martinez-Useros J, Li W, Georgiev-Hristov T, Fernandez-Aceñero MJ, Borrero-Palacios A, Perez N, Celdran A, Garcia-Foncillas J.

Pathol Oncol Res. 2019 Jan;25(1):269-278. doi: 10.1007/s12253-017-0341-0. Epub 2017 Nov 3.

PMID:
29101736
19.

Oncologist's knowledge and implementation of guidelines for breakthrough cancer pain in Spain: CONOCE study.

López López R, Camps Herrero C, Khosravi-Shahi P, Guillem Porta V, Carrato Mena A, Garcia-Foncillas J, Cruz Hernández JJ, Gascón Vilaplana P, Antón Torres A, Diaz-Rubio E, Feyjoo Saus M, Aranda Aguilar E.

Clin Transl Oncol. 2018 May;20(5):613-618. doi: 10.1007/s12094-017-1756-5. Epub 2017 Oct 3.

PMID:
28975575
20.

Incorporating BEAMing technology as a liquid biopsy into clinical practice for the management of colorectal cancer patients: an expert taskforce review.

García-Foncillas J, Alba E, Aranda E, Díaz-Rubio E, López-López R, Tabernero J, Vivancos A.

Ann Oncol. 2017 Dec 1;28(12):2943-2949. doi: 10.1093/annonc/mdx501. Review.

Supplemental Content

Loading ...
Support Center